Status:
COMPLETED
Use of Ointments in Prevention of Catheter Related Infections in PD
Lead Sponsor:
University Health Network, Toronto
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Peritoneal dialysis (PD) is used for the treatment of end-stage renal disease in approximately 25% of patients requiring dialysis in Canada. The most common complication is bacterial infection or 'per...
Detailed Description
Peritoneal dialysis (PD) is used for the treatment of end-stage renal disease in approximately 25% of patients requiring dialysis in Canada. The most common PD related complication is infective perito...
Eligibility Criteria
Inclusion
- Able and willing to provide informed consent\*
- Age over 18 years
- Has a peritoneal dialysis catheter in situ and
- Is established on PD for more than 3 months (prevalent patients)
- Is undergoing training for or has initiated PD within the last 3 months (incident patients)
- Medically stable (as defined by primary nephrologist)
- Regularly applying mupirocin ointment to catheter exit site
Exclusion
- Presence of acute renal failure
- Catheter related infection at the time of recruitment or within the previous 3 months
- Use of an oral or IV antibiotic at the time of randomization or within the previous 1 week.
- Known allergy to any component of gentamicin or mupirocin
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00400595
Start Date
February 1 2006
End Date
June 1 2010
Last Update
March 18 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Scarborough General Hospital
Toronto, Ontario, Canada, M1P 2V5
2
University Health Network
Toronto, Ontario, Canada, M5G 2C4